Incidence of New or Worsening Overactive Bladder Among Patients with a Prior SARS-CoV-2 Infection: A Cohort Study

Roberts, Ly Hoang; Zwaans, Bernadette; Peters, Kenneth M.; Chancellor, Michael B.; Padmanabhan, Priya

doi:10.1016/j.euros.2022.10.001

Cited by 10 publications

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the other cluster, Chancellor M searched for the mechanism and treatment of urinary diseases [ [30] , [31] , [32] , [33] ]. And his recent articles focused on comorbidities and/or complications of urinary problems, namely urinary problems occurring together with other diseases, including Alzheimer's disease and SARS-CoV-2 [ 34 , 35 ]. Another active author, YOSHIMURA N, cooperated with Chancellor M in the field of mechanism research and treatment.…”

Section: Discussionmentioning

confidence: 99%

Research trends of acupuncture therapy on stress urinary incontinence from 1992 to 2022: A bibliometric analysis

Wu,

Li,

Shi

et al. 2023

Heliyon

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Research trends of acupuncture therapy on stress urinary incontinence from 1992 to 2022: A bibliometric analysis

Wu,

Li,

Shi

et al. 2023

Heliyon

View full text Add to dashboard Cite

Prospective follow‐up of overactive bladder symptoms in patients with prior SARS‐CoV‐2 infection

Padmanabhan,

Roberts,

Chancellor

et al. 2024

Neurourology and Urodynamics

View full text Add to dashboard Cite

PurposeSARS‐CoV‐2 infection can result in genitourinary symptoms, such as frequency, urgency, nocturia, and pain/pressure. In this study, we followed the progression of overactive bladder (OAB) symptoms in patients that reported new or worsening OAB symptoms after coronavirus disease‐19 (COVID‐19) diagnosis.Materials and MethodsIndividuals from a COVID‐19 serology study were invited to participate in a follow‐up study. Respondents were divided into three groups based on prior COVID‐19 testing. Patients scored symptoms retrospectively before the pandemic, at study onset, and prospectively during 12‐month follow‐up. Genitourinary symptoms were assessed using international consultation on incontinence questionaire for OAB (ICIQ‐OAB). Change in ICIQ‐OAB scores from baseline were calculated. The minimal important difference of one on ICIQ‐OAB is considered a significant change.Results26.0% of participants previously had positive COVID polymerase chain reaction (PCR) test (PCR+), 5.6% a positive serology test only (Ser+), and 65.5% were COVID naïve (COVID−). 23.8% of participants reported a significant increase in ICIQ‐OAB score at study onset compared to prepandemic. ICIQ‐OAB scores were similar at prepandemic but significantly higher at study start (p < 0.001) in PCR+ group. During follow‐up, change in ICIQ‐OAB scores from baseline remained unchanged for COVID− group, but gradually reduced for PCR+, reaching similar levels as COVID− group by 12 months. By 12 months, 71.4% of PCR+, 42.9% of Ser+, and 68.8% of COVID− participants still reported significant increase in ICIQ‐OAB scores.ConclusionsMost COVID‐19 patients experienced return of symptoms to baseline, indicative of the potential resolution of COVID‐associated cystitis. A subset of cases did not, raising questions about the underlying factors contributing to this outcome. Additional research is needed to assess long COVID on urological health.

show abstract

COVID-associated cystitis: the culprit behind the bladder woes post-COVID infection? A review

Dhawan,

Ganduboina,

Dutta

et al. 2023

Int Urol Nephrol

View full text Add to dashboard Cite

Incidence of New or Worsening Overactive Bladder Among Patients with a Prior SARS-CoV-2 Infection: A Cohort Study

Cited by 10 publications

References 28 publications

Research trends of acupuncture therapy on stress urinary incontinence from 1992 to 2022: A bibliometric analysis

Research trends of acupuncture therapy on stress urinary incontinence from 1992 to 2022: A bibliometric analysis

Prospective follow‐up of overactive bladder symptoms in patients with prior SARS‐CoV‐2 infection

COVID-associated cystitis: the culprit behind the bladder woes post-COVID infection? A review

Contact Info

Product

Resources

About